Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients

This publication has 24 references indexed in Scilit:

• Secondary prevention trials after acute myocardial infarction
  The American Journal of Cardiology, 1987
• Fibrin formation and platelet aggregation in patients with acute myocardial infarction: Effects of intravenous and subcutaneous low-dose heparin
  American Heart Journal, 1986
• The Pathogenesis of Atherosclerosis — An Update
  New England Journal of Medicine, 1986
• Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
  Circulation, 1985
• Relationship between platelet aggregation and plasma β-thromboglobulin levels in arteriovascular and renal diseases
  Atherosclerosis, 1985
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984
• HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY
  The Lancet, 1980
• The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus
  European Journal of Clinical Pharmacology, 1980
• The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
  Journal of Clinical Investigation, 1976
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
  Nature, 1962